124 related articles for article (PubMed ID: 37776513)
1. Discrete class I molecules on brain endothelium differentially regulate neuropathology in experimental cerebral malaria.
Fain CE; Zheng J; Jin F; Ayasoufi K; Wu Y; Lilley MT; Dropik AR; Wolf DM; Rodriguez RC; Aibaidula A; Tritz ZP; Bouchal SM; Pewe LL; Urban SL; Chen Y; Chang SY; Hansen MJ; Kachergus JM; Shi J; Thompson EA; Jensen HE; Harty JT; Parney IF; Sun J; Wu LJ; Johnson AJ
Brain; 2024 Feb; 147(2):566-589. PubMed ID: 37776513
[TBL] [Abstract][Full Text] [Related]
2. CD8+ T Cells Induce Fatal Brainstem Pathology during Cerebral Malaria via Luminal Antigen-Specific Engagement of Brain Vasculature.
Swanson PA; Hart GT; Russo MV; Nayak D; Yazew T; Peña M; Khan SM; Janse CJ; Pierce SK; McGavern DB
PLoS Pathog; 2016 Dec; 12(12):e1006022. PubMed ID: 27907215
[TBL] [Abstract][Full Text] [Related]
3. Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria.
Howland SW; Poh CM; Gun SY; Claser C; Malleret B; Shastri N; Ginhoux F; Grotenbreg GM; Rénia L
EMBO Mol Med; 2013 Jul; 5(7):984-99. PubMed ID: 23681698
[TBL] [Abstract][Full Text] [Related]
4. Perivascular Arrest of CD8+ T Cells Is a Signature of Experimental Cerebral Malaria.
Shaw TN; Stewart-Hutchinson PJ; Strangward P; Dandamudi DB; Coles JA; Villegas-Mendez A; Gallego-Delgado J; van Rooijen N; Zindy E; Rodriguez A; Brewer JM; Couper KN; Dustin ML
PLoS Pathog; 2015; 11(11):e1005210. PubMed ID: 26562533
[TBL] [Abstract][Full Text] [Related]
5. Critical role of IL-33 receptor ST2 in experimental cerebral malaria development.
Palomo J; Reverchon F; Piotet J; Besnard AG; Couturier-Maillard A; Maillet I; Tefit M; Erard F; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2015 May; 45(5):1354-65. PubMed ID: 25682948
[TBL] [Abstract][Full Text] [Related]
6. CD8
Ghazanfari N; Gregory JL; Devi S; Fernandez-Ruiz D; Beattie L; Mueller SN; Heath WR
J Immunol; 2021 Sep; 207(6):1578-1590. PubMed ID: 34400523
[TBL] [Abstract][Full Text] [Related]
7. Neuroimmunological blood brain barrier opening in experimental cerebral malaria.
Nacer A; Movila A; Baer K; Mikolajczak SA; Kappe SH; Frevert U
PLoS Pathog; 2012; 8(10):e1002982. PubMed ID: 23133375
[TBL] [Abstract][Full Text] [Related]
8. IFN-γ-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain.
Villegas-Mendez A; Greig R; Shaw TN; de Souza JB; Gwyer Findlay E; Stumhofer JS; Hafalla JC; Blount DG; Hunter CA; Riley EM; Couper KN
J Immunol; 2012 Jul; 189(2):968-79. PubMed ID: 22723523
[TBL] [Abstract][Full Text] [Related]
9. Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA.
Palomo J; Fauconnier M; Coquard L; Gilles M; Meme S; Szeremeta F; Fick L; Franetich JF; Jacobs M; Togbe D; Beloeil JC; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2013 Oct; 43(10):2683-95. PubMed ID: 23780878
[TBL] [Abstract][Full Text] [Related]
10. Brain endothelial cells exposure to malaria parasites links type I interferon signalling to antigen presentation, immunoproteasome activation, endothelium disruption, and cellular metabolism.
Shafi AM; Végvári Á; Zubarev RA; Penha-Gonçalves C
Front Immunol; 2023; 14():1149107. PubMed ID: 36993973
[TBL] [Abstract][Full Text] [Related]
11. Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier.
Nacer A; Movila A; Sohet F; Girgis NM; Gundra UM; Loke P; Daneman R; Frevert U
PLoS Pathog; 2014 Dec; 10(12):e1004528. PubMed ID: 25474413
[TBL] [Abstract][Full Text] [Related]
12. Co-infection with Chikungunya virus alters trafficking of pathogenic CD8
Teo TH; Howland SW; Claser C; Gun SY; Poh CM; Lee WW; Lum FM; Ng LF; Rénia L
EMBO Mol Med; 2018 Jan; 10(1):121-138. PubMed ID: 29113976
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-15 Complex Treatment Protects Mice from Cerebral Malaria by Inducing Interleukin-10-Producing Natural Killer Cells.
Burrack KS; Huggins MA; Taras E; Dougherty P; Henzler CM; Yang R; Alter S; Jeng EK; Wong HC; Felices M; Cichocki F; Miller JS; Hart GT; Johnson AJ; Jameson SC; Hamilton SE
Immunity; 2018 Apr; 48(4):760-772.e4. PubMed ID: 29625893
[TBL] [Abstract][Full Text] [Related]
14. Coenzyme Q10 exhibits anti-inflammatory and immune-modulatory thereby decelerating the occurrence of experimental cerebral malaria.
Nyariki JN; Kimani NM; Kibet PS; Kinuthia GK; Isaac AO
Mol Biochem Parasitol; 2023 Sep; 255():111579. PubMed ID: 37385350
[TBL] [Abstract][Full Text] [Related]
15. Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity.
Briquet S; Lawson-Hogban N; Boisson B; Soares MP; Péronet R; Smith L; Ménard R; Huerre M; Mécheri S; Vaquero C
Infect Immun; 2015 Jul; 83(7):2771-84. PubMed ID: 25916985
[TBL] [Abstract][Full Text] [Related]
16. Perforin Expression by CD8 T Cells Is Sufficient To Cause Fatal Brain Edema during Experimental Cerebral Malaria.
Huggins MA; Johnson HL; Jin F; N Songo A; Hanson LM; LaFrance SJ; Butler NS; Harty JT; Johnson AJ
Infect Immun; 2017 May; 85(5):. PubMed ID: 28264905
[TBL] [Abstract][Full Text] [Related]
17. Suppression of Plasmodium MIF-CD74 signaling protects against severe malaria.
Baeza Garcia A; Siu E; Du X; Leng L; Franke-Fayard B; Janse CJ; Howland SW; Rénia L; Lolis E; Bucala R
FASEB J; 2021 Dec; 35(12):e21997. PubMed ID: 34719814
[TBL] [Abstract][Full Text] [Related]
18. Development of a Novel CD4
Fernandez-Ruiz D; Lau LS; Ghazanfari N; Jones CM; Ng WY; Davey GM; Berthold D; Holz L; Kato Y; Enders MH; Bayarsaikhan G; Hendriks SH; Lansink LIM; Engel JA; Soon MSF; James KR; Cozijnsen A; Mollard V; Uboldi AD; Tonkin CJ; de Koning-Ward TF; Gilson PR; Kaisho T; Haque A; Crabb BS; Carbone FR; McFadden GI; Heath WR
J Immunol; 2017 Dec; 199(12):4165-4179. PubMed ID: 29084838
[TBL] [Abstract][Full Text] [Related]
19. PDL1 Fusion Protein Protects Against Experimental Cerebral Malaria via Repressing Over-Reactive CD8
Wang J; Li Y; Shen Y; Liang J; Li Y; Huang Y; Liu X; Jiang D; Yang S; Zhao Y; Yang K
Front Immunol; 2018; 9():3157. PubMed ID: 30693001
[TBL] [Abstract][Full Text] [Related]
20. The Deubiquitinating Enzyme Cylindromatosis Dampens CD8
Schmid U; Stenzel W; Koschel J; Raptaki M; Wang X; Naumann M; Matuschewski K; Schlüter D; Nishanth G
Front Immunol; 2017; 8():27. PubMed ID: 28203236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
